3CSY image
Deposition Date 2008-04-10
Release Date 2008-07-08
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3CSY
Title:
Crystal structure of the trimeric prefusion Ebola virus glycoprotein in complex with a neutralizing antibody from a human survivor
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.40 Å
R-Value Free:
0.30
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Fab KZ52 heavy chain
Chain IDs:A, C, E, G
Chain Length:226
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Fab KZ52 light chain
Chain IDs:B, D, F, H
Chain Length:217
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein GP1
Gene (Uniprot):GP
Mutations:T42V, T230V
Chain IDs:I, K, M, O
Chain Length:334
Number of Molecules:4
Biological Source:Ebola virus - Mayinga, Zaire, 1976
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein GP2
Chain IDs:J, L, N, P
Chain Length:131
Number of Molecules:4
Biological Source:Ebola virus - Mayinga, Zaire, 1976
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Ligand Molecules
Primary Citation
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.
Nature 454 177 182 (2008)
PMID: 18615077 DOI: 10.1038/nature07082

Abstact

Ebola virus (EBOV) entry requires the surface glycoprotein (GP) to initiate attachment and fusion of viral and host membranes. Here we report the crystal structure of EBOV GP in its trimeric, pre-fusion conformation (GP1+GP2) bound to a neutralizing antibody, KZ52, derived from a human survivor of the 1995 Kikwit outbreak. Three GP1 viral attachment subunits assemble to form a chalice, cradled by the GP2 fusion subunits, while a novel glycan cap and projected mucin-like domain restrict access to the conserved receptor-binding site sequestered in the chalice bowl. The glycocalyx surrounding GP is likely central to immune evasion and may explain why survivors have insignificant neutralizing antibody titres. KZ52 recognizes a protein epitope at the chalice base where it clamps several regions of the pre-fusion GP2 to the amino terminus of GP1. This structure provides a template for unravelling the mechanism of EBOV GP-mediated fusion and for future immunotherapeutic development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures